Integrating Quality of Life in the Care Pathway of Cancer Patients Undergoing Immunotherapy Treatment: Descriptive, Cross-sectional Survey of an Online Patient Community's Experiences and Expectations
BackgroundNew cancer treatments, such as immune checkpoint inhibitors (ICIs), can improve survival and health-related quality of life (HRQoL) in patients with cancer. Although long-term monitoring of HRQoL has been shown to improve survival, integration of HRQoL into everyday...
Main Authors: | Ophélie Wilczynski, Anthony Boisbouvier, Lise Radoszycki, François-Emery Cotté, Anne-Françoise Gaudin, Hervé Lemasson |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-01-01
|
Series: | Journal of Medical Internet Research |
Online Access: | https://www.jmir.org/2022/1/e25792 |
Similar Items
-
Organizational Impact of Immunotherapies in Advanced Cancers in France
by: Valentine Grumberg, et al.
Published: (2023-08-01) -
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting
by: Jean-Baptiste Assié, et al.
Published: (2023-01-01) -
Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy
by: Joshua Hofbauer, et al.
Published: (2022-05-01) -
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
by: Cotté François-Emery, et al.
Published: (2011-06-01) -
Upright patient positioning for gantry-free breast radiotherapy: feasibility tests using a robotic chair and specialised bras
by: Sophie Boisbouvier, et al.
Published: (2023-09-01)